Castle Biosciences Inc (CSTL) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Castle Biosciences Inc   (NASDAQ: CSTL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Castle Biosciences Inc Profitability Comparisons

Select each Category to receive further Information




CSTL Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 77.11 % 39.94 % 54.17 % 38.76 %
Gross Margin (Q2 TTM) 77.26 % 40.4 % 55.57 % 38.09 %
Gross Profit Margin 5 Yr. Avg. 80.12 % 41.48 % 53.76 % 33.44 %
EBITDA Margin (Q2 MRQ) 6.17 % 13.28 % 19.62 % 20.72 %
EBITDA Margin (Q2 TTM) 5.01 % 13.84 % 21.02 % 19.28 %
EBITDA Margin 5 Yr. Avg. 9.32 % 15.62 % 31.89 % 22.82 %
Operating Margin (Q2 MRQ) -2.96 % 8.21 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) -8.99 % 8.63 % 17.93 % 16.33 %
Operating Margin 5 Yr. Avg. --27.3 % 8.63 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 6.41 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) -0 % 7.53 % 12.85 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. 2.6 % 7.36 % 10.45 % 12.49 %
Net Margin (Q2 MRQ) -0.36 % 5.07 % 8.14 % 11.41 %
Net Margin (Q2 TTM) -0.06 % 5.61 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. 4.81 % 5.18 % 6.23 % 9.95 %



Business Segment Profit Margin
 
Dermatologic
  Explore Dermatologic Segment  -
Non-Dermatologic
  Explore Non-Dermatologic Segment  -
Reportable Segment
  Explore Reportable Segment Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) 6.33 % 14.01 % 0.21 % 1.39 %
Free Cash Flow Margin (Q2 TTM) -0.14 % 9.19 % 14.06 % 9.26 %
Free Cash Flow Margin 5 Yr. Avg. - 10.67 % 15.38 % 14.46 %
Net Cash Flow Margin (Q2 MRQ) 0 % 9.5 % -0.02 % 0.13 %
Net Cash Flow Margin (Q2 TTM) -5.17 % 3.4 % 0.09 % 1.79 %
Net Cash Flow Margin 5 Yr. Avg. - 1.3 % 3.13 % 5.85 %
Effective Tax Rate (Q2 MRQ)